Circumvent

About

Circumvent is a biotech company

Portland,Oregon,United States
1 - 10

Highlights

Details

Last Funding Type: Seed
Last Funding Money Raised: $4.09M
Industries: Biotechnology,Health Care,Pharmaceutical
Founded date: Jan 1, 2017
Number Of Employee: 1 - 10
Operating Status: Active

Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by NIH/NINDS, YC Bio, Heritage Provider Network, the Longevity Fund, and additional investors.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$7.93M

Circumvent has raised a total of $7.93M in funding over 2 rounds. Their latest funding was raised on Nov 1, 2021 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 1, 2021	Grant	$303K	—	—	—	Detail
Nov 1, 2021	Grant	$495K	—	—	—	Detail
Nov 1, 2021	Grant	$2.89M	—	—	—	Detail
Dec 9, 2020	Seed	$4.09M	3	—	—	Detail
Mar 18, 2019	Pre-seed	$150K	1	Y Combinator	—	Detail